300 related articles for article (PubMed ID: 20097731)
1. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.
Zhang Z; Kobayashi S; Borczuk AC; Leidner RS; Laframboise T; Levine AD; Halmos B
Carcinogenesis; 2010 Apr; 31(4):577-86. PubMed ID: 20097731
[TBL] [Abstract][Full Text] [Related]
2. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
3. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
4. Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter.
Ekerot M; Stavridis MP; Delavaine L; Mitchell MP; Staples C; Owens DM; Keenan ID; Dickinson RJ; Storey KG; Keyse SM
Biochem J; 2008 Jun; 412(2):287-98. PubMed ID: 18321244
[TBL] [Abstract][Full Text] [Related]
5. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
6. A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts.
Blüthgen N; Legewie S; Kielbasa SM; Schramme A; Tchernitsa O; Keil J; Solf A; Vingron M; Schäfer R; Herzel H; Sers C
FEBS J; 2009 Feb; 276(4):1024-35. PubMed ID: 19154344
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma.
Lee H; Kim JM; Huang SM; Park SK; Kim DH; Kim DH; Lee CS; Suh KS; Yi ES; Kim KH
Pathol Res Pract; 2011 Jul; 207(7):428-32. PubMed ID: 21680106
[TBL] [Abstract][Full Text] [Related]
8. Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway.
Wang XL; Lu SC; Sun C; Jin WG; Fan YW; Shu YS; Shi HC; Min LF
Cancer Biol Ther; 2021 Apr; 22(4):324-332. PubMed ID: 33970779
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of dual-specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA-28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2.
Kanda Y; Mizuno A; Takasaki T; Satoh R; Hagihara K; Masuko T; Endo Y; Tanabe G; Sugiura R
Genes Cells; 2021 Feb; 26(2):109-116. PubMed ID: 33249692
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
11. NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
Ingram K; Samson SC; Zewdu R; Zitnay RG; Snyder EL; Mendoza MC
Oncogene; 2022 Jan; 41(2):293-300. PubMed ID: 34689179
[TBL] [Abstract][Full Text] [Related]
12. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development.
Li C; Scott DA; Hatch E; Tian X; Mansour SL
Development; 2007 Jan; 134(1):167-76. PubMed ID: 17164422
[TBL] [Abstract][Full Text] [Related]
13. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
[TBL] [Abstract][Full Text] [Related]
14. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
15. P2X7 Nucleotide and EGF Receptors Exert Dual Modulation of the Dual-Specificity Phosphatase 6 (MKP-3) in Granule Neurons and Astrocytes, Contributing to Negative Feedback on ERK Signaling.
Queipo MJ; Gil-Redondo JC; Morente V; Ortega F; Miras-Portugal MT; Delicado EG; Pérez-Sen R
Front Mol Neurosci; 2017; 10():448. PubMed ID: 29375309
[TBL] [Abstract][Full Text] [Related]
16. DUSP6 regulates drug sensitivity by modulating DNA damage response.
Bagnyukova TV; Restifo D; Beeharry N; Gabitova L; Li T; Serebriiskii IG; Golemis EA; Astsaturov I
Br J Cancer; 2013 Aug; 109(4):1063-71. PubMed ID: 23839489
[TBL] [Abstract][Full Text] [Related]
17. Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3.
Donaubauer EM; Law NC; Hunzicker-Dunn ME
J Biol Chem; 2016 Sep; 291(37):19701-12. PubMed ID: 27422819
[TBL] [Abstract][Full Text] [Related]
18. ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers.
Martin-Vega A; Earnest S; Augustyn A; Wichaidit C; Gazdar A; Girard L; Peyton M; Kollipara RK; Minna JD; Johnson JE; Cobb MH
bioRxiv; 2023 Jun; ():. PubMed ID: 37398419
[TBL] [Abstract][Full Text] [Related]
19. Dual specificity phosphatase DUSP6 promotes endothelial inflammation through inducible expression of ICAM-1.
Hsu SF; Lee YB; Lee YC; Chung AL; Apaya MK; Shyur LF; Cheng CF; Ho FM; Meng TC
FEBS J; 2018 May; 285(9):1593-1610. PubMed ID: 29493888
[TBL] [Abstract][Full Text] [Related]
20. Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Moncho-Amor V; Pintado-Berninches L; Ibañez de Cáceres I; Martín-Villar E; Quintanilla M; Chakravarty P; Cortes-Sempere M; Fernández-Varas B; Rodriguez-Antolín C; de Castro J; Sastre L; Perona R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
